Sera Prognostics (SERA) Research & Development (2020 - 2026)
Sera Prognostics' (SERA) quarterly Research & Development came in at $3.0 million in Q1 2026, up 106.12% YoY from $1.5 million in Q1 2025, and up 81.98% on a QoQ basis from $1.7 million in Q4 2025.
Sera Prognostics (SERA) Research & Development (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of Research & Development data on file, last reported at $3.0 million in Q1 2026.
- Quarterly Research & Development rose 106.12% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.8 million (down 46.39% YoY) and the FY2025 annual result came in at $6.5 million, down 55.55% from the prior year.
- Research & Development improved to $3.0 million in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $11.2 million in Q4 2024 to a low of $1.2 million in Q3 2024.
- A 5-year average of $3.3 million and a median of $3.1 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2024 — Research & Development jumped 188.14% — and 2025, when it plunged 85.16%.
- Tracing SERA's Research & Development over 5 years: stood at $3.1 million in 2022, then increased by 27.5% to $3.9 million in 2023, then surged by 188.14% to $11.2 million in 2024, then sank by 85.16% to $1.7 million in 2025, then soared by 81.98% to $3.0 million in 2026.
- The last three Research & Development figures came in at $3.0 million (Q1 2026), $1.7 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Sera Prognostics | 100.45 Mn | 100.45 Mn | -20,000.00 | 3.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.49 Mn |
| Mar 31, 2026 | 3.03 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Sep 30, 2025 | 3.28 Mn |
| Jun 30, 2025 | 1.82 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Dec 31, 2024 | 11.22 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 4.41 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 2.87 Mn |
| Mar 31, 2023 | 4.10 Mn |
| Dec 31, 2022 | 3.06 Mn |
| Sep 30, 2022 | 4.18 Mn |
| Jun 30, 2022 | 3.26 Mn |
| Mar 31, 2022 | 4.46 Mn |
| Dec 31, 2021 | 5.24 Mn |
| Sep 30, 2021 | 2.69 Mn |